Skip to main content
Erschienen in: International Urogynecology Journal 11/2007

01.11.2007 | Original Article

Risk factors for uterine prolapse in Nepal

verfasst von: Barbara Bodner-Adler, Chanda Shrivastava, Klaus Bodner

Erschienen in: International Urogynecology Journal | Ausgabe 11/2007

Einloggen, um Zugang zu erhalten

Abstract

Uterine prolapse is a significant public health problem in Nepal. The aim of this study was to determine the prevalence of uterine prolapse and to define possible risk factors for this disease in the Kathmandu Valley of Nepal. This clinical report consists of an analysis of data from Dr. Iwamura Memorial Hospital and Research Center (IMHARC) in Bhaktapur, between July 1 and September 30, 2006. This analysis was restricted to a sample that included all women with complaints of uterine prolapse (second- or third-degree prolapse) diagnosed and treated at the IMHARC. During a 3-month period, 96 women were diagnosed and treated with uterine prolapse. The median age at the time of clinical presentation was 50 years, and the median maternal weight was 45 kg. In average, the women gave birth to four children vaginally. Most of the affected women were smoking, and most of them were postmenopausal. Thirty-five percent of the affected patients had a chronic obstructive pulmonary disease (COPD), 16% suffered from hypertension and 5% had diabetes mellitus. The majority of the women with uterine prolapse were of Newari origin (84%), and nearly all patients reported that they were working heavily during pregnancy as well as in the postpartum period (87%). We found several risk factors for uterine prolapse in Nepal. Especially extensive physical labor during pregnancy and immediately after delivery, low availability of skilled birth attendants, smoking while having COPD and low maternal weight due to lack of nutritious food are mainly responsible for this common disease. In our opinion, extensive information, prevention programs and early management of genital prolapse should be the first steps to reduce this significant social and public health problem in Nepal.
Literatur
1.
Zurück zum Zitat Bonetti TR, Erpelding A, Pathak LR (2004) Listening to “felt need”: investigating genital prolapse in western Nepal. Reprod Health Matters 12(23):166–175PubMedCrossRef Bonetti TR, Erpelding A, Pathak LR (2004) Listening to “felt need”: investigating genital prolapse in western Nepal. Reprod Health Matters 12(23):166–175PubMedCrossRef
2.
Zurück zum Zitat Westergren Söderberg M, Falconer C, Byström B, Malmström A, Ekman G (2004) Young women with genital prolapse have a low collagen concentration. Acta Obstet Gynecol Scand 83:1193–1198PubMedCrossRef Westergren Söderberg M, Falconer C, Byström B, Malmström A, Ekman G (2004) Young women with genital prolapse have a low collagen concentration. Acta Obstet Gynecol Scand 83:1193–1198PubMedCrossRef
3.
Zurück zum Zitat Center for Agro-Ecology and Development (CAED) (2006) Uterine prolapse widespread. Post Report. Nepal Center for Agro-Ecology and Development (CAED) (2006) Uterine prolapse widespread. Post Report. Nepal
4.
Zurück zum Zitat Subba B, Adhikari D, Bhattarai T (2003) The neglected case of the fallen womb. Himal South Asian, Nepal Subba B, Adhikari D, Bhattarai T (2003) The neglected case of the fallen womb. Himal South Asian, Nepal
5.
Zurück zum Zitat Marahatta RK, Shah A (2003) Genital prolapse in women of Bhaktapur, Nepal. Nepal Med Coll J 5(1):31–33PubMed Marahatta RK, Shah A (2003) Genital prolapse in women of Bhaktapur, Nepal. Nepal Med Coll J 5(1):31–33PubMed
6.
Zurück zum Zitat Samuelsson EC, Victor FT, Tibblin G, Svardsudd KF (1999) Signs of genital prolapse in a Swedish population of women 20–59 years of age and possible related factors. Am J Obstet Gynecol 180:299–305PubMedCrossRef Samuelsson EC, Victor FT, Tibblin G, Svardsudd KF (1999) Signs of genital prolapse in a Swedish population of women 20–59 years of age and possible related factors. Am J Obstet Gynecol 180:299–305PubMedCrossRef
7.
Zurück zum Zitat Swift SE (2000) The distribution of pelvic organ support in a population of female subjects seen for routine gynecologic health care. Am J Obstet gynecol 183(2):277–285PubMedCrossRef Swift SE (2000) The distribution of pelvic organ support in a population of female subjects seen for routine gynecologic health care. Am J Obstet gynecol 183(2):277–285PubMedCrossRef
8.
Zurück zum Zitat Progetto Menopausa Italia Study Group (2000) Risk factors for genital prolapse in non-hysterectomized women around menopause. Results from a large cross-sectional study in menopausal clinics in Italy. Eur J Obstet Reprod Biol 93(2):135–140CrossRef Progetto Menopausa Italia Study Group (2000) Risk factors for genital prolapse in non-hysterectomized women around menopause. Results from a large cross-sectional study in menopausal clinics in Italy. Eur J Obstet Reprod Biol 93(2):135–140CrossRef
Metadaten
Titel
Risk factors for uterine prolapse in Nepal
verfasst von
Barbara Bodner-Adler
Chanda Shrivastava
Klaus Bodner
Publikationsdatum
01.11.2007
Verlag
Springer-Verlag
Erschienen in
International Urogynecology Journal / Ausgabe 11/2007
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-007-0331-y

Weitere Artikel der Ausgabe 11/2007

International Urogynecology Journal 11/2007 Zur Ausgabe

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.